FDA Approved Biologics and Pending Applications
denosumab-nxxp
aBL 761444
follitropin alfa/beta
BL 021211
adalimumab-bwwd
aBL 761059
pertuzumab
HLX11 Approval Pending
chorionic gonadotropin
BL 017692
tocilizumab-bavi
aBL 761354
U.S. Patent Litigations
PERJETA / HLX112:25-cv-14648 (D.N.J.)PROLIA / XGEVA / BILDYOS / BILPREVDA1:25-cv-12160 (D.N.J.)